The impact of sodium–glucose cotransporter inhibitors on blood pressure: a meta-analysis and metaregression of 111 randomized-controlled trials

aDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore

bDepartment of Cardiology, National University Heart Centre Singapore, Singapore, Singapore

Correspondence to Ching-Hui Sia, MBBS, MRCP, Department of Cardiology, National University Heart Centre Singapore, 1E Kent Ridge Road, NUHS Tower Block Level 9, Singapore 119228, Singapore. Tel: +65 6779 5555; e-mail: [email protected]

Abbreviations: PRISMA, Preferred Reporting Items of Systematic Reviews and Meta-Analyses; SGLT, sodium–glucose cotransporter; SGLT1/2, sodium–glucose cotransporter 1/2; SGLT1, sodium–glucose cotransporter 1; SGLT2, sodium–glucose cotransporter 2

Received 17 August, 2021

Revised 28 June, 2022

Accepted 5 July, 2022

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.jhypertension.com).

留言 (0)

沒有登入
gif